【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Chemotherapy Induced Neutropenia Overview 10
Therapeutics Development 11
Pipeline Products for Chemotherapy Induced Neutropenia – Overview 11
Pipeline Products for Chemotherapy Induced Neutropenia – Comparative Analysis 12
Chemotherapy Induced Neutropenia – Therapeutics under Development by Companies 13
Chemotherapy Induced Neutropenia – Therapeutics under Investigation by Universities/Institutes 16
Chemotherapy Induced Neutropenia – Pipeline Products Glance 17
Late Stage Products 17
Clinical Stage Products 18
Early Stage Products 19
Unknown Stage Products 20
Chemotherapy Induced Neutropenia – Products under Development by Companies 21
Chemotherapy Induced Neutropenia – Products under Investigation by Universities/Institutes 24
Chemotherapy Induced Neutropenia – Companies Involved in Therapeutics Development 25
Bio-Ker s.r.l 25
Biogenomics Limited 26
Bolder Biotechnology, Inc. 27
Cellerant Therapeutics, Inc. 28
Coherus BioSciences, Inc. 29
Dong-A Socio Group 30
Generon (Shanghai) Corporation Ltd. 31
Hanmi Pharmaceuticals, Co. Ltd. 32
Io Therapeutics, Inc. 33
Mycenax Biotech Inc. 34
Myelo Therapeutics GmbH 35
Octapharma AG 36
PharmaEssentia Corporation 37
Reliance Life Sciences Pvt. Ltd. 38
Richter Gedeon Nyrt. 39
Sandoz Inc. 40
Sandoz International GmbH 41
Teva Pharmaceutical Industries Limited 42
UAB Profarma 43
USV Limited 44
Welichem Biotech Inc. 45
XBiotech USA, Inc. 46
Chemotherapy Induced Neutropenia – Therapeutics Assessment 47
Assessment by Monotherapy Products 47
Assessment by Target 48
Assessment by Mechanism of Action 50
Assessment by Route of Administration 52
Assessment by Molecule Type 54
Drug Profiles 56
balugrastim – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
BBT-007 – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
BBT-015 – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
BBT-018 – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
BK-0026 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
Cell Therapy for Chemotherapy Induced Neutropenia – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
F-627 – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
filgrastim – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
filgrastim – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
filgrastim – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
filgrastim – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
filgrastim – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
filgrastim – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
filgrastim – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
filgrastim (recombinant) – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
GW-003 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
HM-10460A – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
IRX-4310 – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
lipegfilgrastim – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
Myelo-001 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
pegfilgrastim – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
pegfilgrastim – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
pegfilgrastim – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
pegfilgrastim – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
pegfilgrastim – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
pegfilgrastim – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
pegfilgrastim – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
pegfilgrastim – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
Recombinant Protein for Chemotherapy Induced Neutropenia – Drug Profile 87
Product Description 87
Mechanism of Action 87
R&D Progress 87
romyelocel-L – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
TXA-302 – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
WBI-2100 – Drug Profile 91
Product Description 91
Mechanism of Action 91
R&D Progress 91
Chemotherapy Induced Neutropenia – Recent Pipeline Updates 92
Chemotherapy Induced Neutropenia – Dormant Projects 98
Chemotherapy Induced Neutropenia – Discontinued Products 100
Chemotherapy Induced Neutropenia – Product Development Milestones 101
Featured News & Press Releases 101
Dec 08, 2014: Generon Presents the Global Phase II Study Results for F-627 (benegrastim) at the American Society of Hematology 56th Annual Meeting at San Francisco 101
Sep 09, 2014: Spectrum Pharmaceuticals Makes Decision to Advance SPI-2012, a Novel Long-Acting GCSF, to Phase 3 Due to Positive Phase 2 Results in its Collaboration Program with Hanmi Pharm 102
May 28, 2014: Spectrum Pharmaceuticals Completes Enrollment in Phase 2 Trial of SPI-2012 – A Novel Long-Acting Granulocyte Colony Stimulating Factor to Treat Chemotherapy-induced Neutropenia 103
Mar 25, 2014: Sandoz receives approval for biosimilar filgrastim in Japan 103
Nov 18, 2013: Teva announces Launch of LONQUEX Injection 104
Jul 22, 2013: Zarzio overtakes Neupogen and Granocyte to become most prescribed daily G-CSF in Europe 105
Jun 03, 2013: Teva’s Lonquex Receives Positive Opinion From CHMP For Reduction Of Chemotherapy-induced Neutropenia 105
Apr 25, 2013: Sandoz Files For Marketing Authorization Of Biosimilar Filgrastim In Japan 106
Apr 08, 2013: Spectrum Pharma Initiates Phase II Study Of Long-acting GCSF Drug Candidate SPI-2012 For Treatment Of Chemotherapy-induced Neutropenia 106
Jan 07, 2013: Generon Initiates Phase I/II Clinical Trial Of F-627 For Treatment Of Breast Cancer In China 107
Appendix 108
Methodology 108
Coverage 108
Secondary Research 108
Primary Research 108
Expert Panel Validation 108
Contact Us 109
Disclaimer 109
【レポート販売概要】
■ タイトル:化学療法誘発性好中球減少(Chemotherapy Induced Neutropenia)の治療薬パイプライン動向(2015年上半期版)■ 英文:Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6036IDB
■ 調査対象地域:グローバル
- Gantenerumab (Alzheimer’s Disease):市場予測と分析(~2022)Gantenerumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Gantenerumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic ther …
- 非侵襲的脳損傷監視装置の世界市場分析:製品別(監視装置、消耗品)、エンドユーザー別(病院、神経センター)、セグメント予測The global non-invasive brain trauma monitoring devices market is expected to reach USD 15.12 billion by 2024, according to a new report by Grand View Research, Inc. The rising burden of Traumatic Brain Injuries (TBI) is a leading cause of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. As a result, there are numerous initiatives taken at the regional and global levels to …
- 産業用イーサネットの世界市場予測(~2022):ハードウェア、ソフトウェア、サービス、プロトコルAccording to the new market research report on industrial Ethernet, thismarket is expected to grow at a CAGR of 16.8% between 2016 and 2022, from USD 19.43 billion in 2015 to USD 59.20 billion by 2022. The major driver for the growth of the industrial Ethernet market is the growing adoption of IIoT. In various manufacturing industries, the potential of IIoT to improve productivity in production pr …
- 航空宇宙及び軍事用補助動力装置(APU)のグローバル市場(2014 – 2019)This report provides an in-depth analysis of the global aerospace and military APU market. It provides information of the current trends in the market with respect to regions, countries, technologies, and applications market. It throws light on the current market trends, drivers, restraints, opportunities, and challenges faced in the market that will impact the growth of this market. It analyzes t …
- 麻薬スキャナーの世界市場2017-2021About Narcotics Scanner Narcotics are drugs that have several medicinal uses such as severe pain control, anxiety relief, sleep induction, and numbing the senses. However, narcotics are also abused as drugs when taken without the prescription of a physician. These are the non-medicinal uses of narcotics. Narcotics are often smuggled, and this has paved way for the narcotics drug trade. The traffic …
- オシロスコープの世界市場2017-2021About Oscilloscopes An oscilloscope is a testing and measuring device used to monitor voltage or current passed to or from an electronic component or device. Oscilloscopes were originally available only in analog; however, digital versions of these devices are available currently. A digital oscilloscope requires an analog-to-digital converter (ADC) to convert voltage into digital information. It s …
- クーリングファブリックの世界市場予測(~2024年)The cooling fabrics market is projected to grow at a CAGR of 9.1% between 2019 and 2024The cooling fabrics market is estimated to be USD 2.4 billion in 2019 and is expected to reach USD 3.7 billion by 2024, at a CAGR of 9.1% from 2019 to 2024. Increasing demand for sports apparel, protective wearing and growing research & development for cooling fabrics are the main factors that have led to the gr …
- 世界のハロゲン電球市場2015The Global Halogen Bulbs Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Halogen Bulbs industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Halogen Bulbs market analysis is provided for the international markets including development trends, competit …
- 真珠光沢顔料の世界市場分析:製品別(天然パールエッセンス、二酸化チタン、酸化第二鉄、コンビネーションマイカ)、用途別(塗料・コーティング、プラスチック、印刷インキ、化粧品)、セグメント予測The global pearlescent pigment market is expected to reach USD 547.8 million by 2022, according to a new report by Grand View Research, Inc. Growing demand for high performance, high brilliance paints on account of expanding automotive & construction industries in emerging markets is expected to remain a key driving factor for the global market. Shift in trend towards reducing VOC emissions and gr …
- Noble Energy, Inc.:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Noble Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Noble Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- フリークエントフライヤー向けクレジットカードのベストプラクティスThe report provides information and insights on into market trends for credit cards targeted at frequent flyers, including: • A global snapshot of frequent flyer credit card dynamics and market drivers. • Comprehensive analysis of key trends expected to shape the market over the next five years. • Analysis of industry best practice through detailed case studies. • Detailed analysis of key markets, …
- 世界の高電圧直流(HVDC)変換所市場動向及び予測(~2019)This report estimates the HVDC converter station market size in terms of value. The volume market is estimated on the basis of the total number of projects commissioned from 2012 till 2019. The report estimates the market size of HVDC converter station while comprising overhead and underground systems. The HVDC converter station market is driven by increment in offshore wind farms, government ince …
- 世界における小型自動車用電気モーター市場動向と予測(~2029)This latest just-auto report edition offers a global review of the OE automotive electric motors sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE electric motors market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their str …
- Arsenal Energy Inc.:石油・ガスバリューチェーン分析レポート2013Arsenal Energy Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Arsenal Energy Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Arsenal Energy Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
- Galp Energia SGPS S.A.:石油・ガスバリューチェーン分析レポート2013Galp Energia SGPS S.A. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Galp Energia SGPS S.A." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Galp Energia SGPS S.A.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …